Skip to Content
Skip to Content

Applications for authorisation - current consultations

Applications for authorisation - current consultations

The application for authorisation process includes a period of public consultation. It lasts for eight weeks.

 

Instructions for providing comments

Anyone can provide information on alternative substances or technologies for the uses of Annex XIV substances included in applications for authorisation. Those most likely to be interested are companies, organisations representing industry or civil society, individual citizens, as well as public authorities.

The following documents describe the public consultation process:

 

Document Description  
Submission of information on alternatives Instructions of how interested third parties can submit information for the public consultation on alternatives for applications for authorisation. Download
Format for "Public version" Download
Format for "Complete version" Download

 

Provide your comments

In order to facilitate the work of ECHA's Committees in reviewing the comments received, you are kindly invited to provide your comments in English preferably. By clicking on a link in the table below, you will get access to the full broad information on the use applied for, and to the related commenting form. Comments are welcomed from the EU or beyond.

Consultations close at 23:59 Helsinki time (EET).

Adopted opinions and previous consultations on applications for authorisation

 
0171-02 Initial 4-Nonylphenol, branched and linear, ethoxylated - - 09/10/2019 Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in the formulation and filling of in vitro diagnostic (IVD) assays specified in Appendix 1 to the AoA.
0171-04 Initial 4-Nonylphenol, branched and linear, ethoxylated - - 09/10/2019 Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in in vitro diagnostic (IVD) assays specified in Appendix 1 to the AoA.
0171-06 Initial 4-Nonylphenol, branched and linear, ethoxylated - - 09/10/2019 Roche Diagnostics GmbH Use of Octyl- and Nonylphenolethoxylates in the production of proteins and the conjugation of latex beads, both being used as components or for the production of components of in vitro diagnostic (IVD) assays, research or quality control products and other, e.g. analytical applications (processes specified in Appendix 1 to the AoA)
0172-01 Initial 4-Nonylphenol, branched and linear, ethoxylated - - 09/10/2019 GE Healthcare Bio-Sciences AB Industrial use of emulsifiers containing nonylphenols ethoxylated for the manufacture of chromatography resins used by the biopharmaceutical industry, food & beverage sector and academia
Showing 4 results.



 

 

Related links

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live1